Patent details

Basic Information

Publication number:

EP4147053

PCT Application Number:

EP2021062090

Type:

European Patent Granted for LU

Legal Status:

Unitary Effect Registered

Application number:

EP217232776

PCT Publication Number:

WO2021224438

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPY

French Title of Invention:

ANTXR1 ENTANT QUE BIOMARQUEUR DES POPULATIONS DE FIBROBLASTES IMMUNOSUPPRESSEURS ET SON UTILISATION POUR LA PRÉDICTION DE LA RÉPONSE À L'IMMUNOTHÉRAPIE

German Title of Invention:

ANTXR1 ALS BIOMARKER VON IMMUNOSUPPRESSIVEN FIBROBLASTPOPULATIONEN UND DESSEN VERWENDUNG ZUR VORHERSAGE DER REAKTION AUF EINE IMMUNTHERAPIE

SPC Number:

Unitary Effect

Unitary Effect Requested:

Yes

Unitary Effect Request Filing Date:

17/02/2026

Link to UPP Register:

European Patent Register

Unitary Effect Request Withdrawal Date:

Unitary Effect Status:

Unitary Effect Registered

Unitary Effect Acceptance Decision Date:

23/02/2026

Unitary Effect Rejection Decision Date:

Unitary Effect Date:

28/01/2026

Unitary Effect Registration Date:

23/02/2026

Unitary Effect Re-establishment of rights Filing Date:

Unitary Effect Re-establishment of rights EPO Decision :

Unitary Effect Re-establishment of rights EPO Decision Date:

Explanatory Text UE:

Safety Net Request Date:

Safety Net Decision Date:

Safety Net Decision Outcome:

SPC Number:

Dates

Filing date:

07/05/2021

Grant date:

28/01/2026

EP Publication Date:

15/03/2023

PCT Publication Date:

11/11/2021

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/01/2026

EP B1 Publication Date:

28/01/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

07/05/2041

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/01/2026

 

 

Name:

Institut Curie

Address:

26, rue d'Ulm, 75248 Paris Cedex 05, France (FR)

Name:

Institut National de la Santé et de la Recherche Médicale (INSERM)

Address:

101 rue de Tolbiac, 75013 Paris, France (FR)

History of Owners

From:

21/01/2026

To:

09/01/2026

Name:

Institut Curie

Address:

26, rue d'Ulm, 75248 Paris Cedex 05, France (FR)

Name:

Institut National de la Santé et de la Recherche Médicale (INSERM)

Address:

101 rue de Tolbiac, 75013 Paris, France (FR)

Inventor

1

Name:

MECHTA-GRIGORIOU, Fatima

Address:

France (FR)

2

Name:

HOCINE, Rachid, Hocine

Address:

United States (US)

3

Name:

KIEFFER, Yann

Address:

France (FR)

4

Name:

VINCENT-SALOMON, Anne

Address:

France (FR)

Priority

Priority Number:

20305454

Priority Date:

07/05/2020

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

G01N 33/574; C07K 16/00;

Publication

European Patent Bulletin

1

Issue number:

202605

Publication date:

28/01/2026

Description:

Grant (B1)

2

Issue number:

202607

Publication date:

11/02/2026

Description:

Change of owner's name or address

3

Issue number:

202613

Publication date:

25/03/2026

Description:

Unitary Effect Request Receipt

4

Issue number:

202613

Publication date:

25/03/2026

Description:

Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages